Analytical Control of Darunavir Tablet Dosage Forms. Part I.


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Purposeful development of special methods to be included into pharmacopoeial monographs on the quality of darunavir (DRV) preparations is shown to allow the use of expensive imported standard samples (SSs) for drug analysis to be avoided. Part I of the present work describes these methods and their validation. UV spectrophotometry is proposed in the “Authenticity” section for detecting DRV by the coincidence of extrema in the spectrum of an aqueous MeOH extract (pH 9) with well-known peaks in the spectrum of deprotonated DRV at 230 nm (minimum) and 267 nm (maximum). This section also requires GC analysis for solvated EtOH, the presence of which indicates that DRV ethanolate was used as the active pharmaceutical ingredient (API) and the absence of which, that non-solvated amorphous DRV was used. The significant increase in the accuracy of the quantitative determination and the sharp reduction in its duration allow the use of SSs to be avoided. For this reason, the “Dissolution” section proposes determining the DRV concentration in the dissolution medium (pH 3) by spectrophotometry using a method that requires experimental determination of the specific absorption coefficient \( \left({A}_{1\mathrm{cm}}^{1\%}\right) \) of DRV solutions in this medium at the maximum (267 nm). The established value \( \left({A}_{1\mathrm{cm}}^{1\%}\right. \) = (393.4 ± 2) cm–1 was a physicochemical constant with a relative standard deviation RSD < 1% at confidence level α = 0.05.

Об авторах

M. Goizman

Drug Technology Co.

Автор, ответственный за переписку.
Email: goizmanmi@gmail.com
Россия, 2a Rabochaya St., Khimki, Moscow Oblast, 141400

A. Korlyukov

A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences

Email: goizmanmi@gmail.com
Россия, 28 Vavilova St., Moscow, 119991

K. Suponitskii

A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences

Email: goizmanmi@gmail.com
Россия, 28 Vavilova St., Moscow, 119991

N. Shimanovskii

N. I. Pirogov National Research Medical University

Email: goizmanmi@gmail.com
Россия, 1 Ostrovityanova St., Moscow, 117997

T. Popova

Drug Technology Co.

Email: goizmanmi@gmail.com
Россия, 2a Rabochaya St., Khimki, Moscow Oblast, 141400

A. Popova

Drug Technology Co.

Email: goizmanmi@gmail.com
Россия, 2a Rabochaya St., Khimki, Moscow Oblast, 141400

O. Glotova

Drug Technology Co.

Email: goizmanmi@gmail.com
Россия, 2a Rabochaya St., Khimki, Moscow Oblast, 141400

O. Zotova

Drug Technology Co.

Email: goizmanmi@gmail.com
Россия, 2a Rabochaya St., Khimki, Moscow Oblast, 141400

G. Tikhomirova

Drug Technology Co.

Email: goizmanmi@gmail.com
Россия, 2a Rabochaya St., Khimki, Moscow Oblast, 141400


© Springer Science+Business Media, LLC, part of Springer Nature, 2018

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах